CD8A and neoplasm: Across all factors, including PNI, LVI, mucinous histology, surgical tumor grade, yPT, and yPN stages, no statistically significant differences were observed in pre- or post-treatment CD8+ TIL counts and post-to-pre-treatment CD8+ count ratio.